Esoteric Investments is a growth equity firm investing in primary rounds and secondaries across leading technology, artificial intelligence, defense, data center, semiconductor, and consumer companies.
The companies that will define the coming era — the model laboratories, the silicon designers, the autonomy primes, the hyperscalers — are staying private longer and compounding faster than any prior cohort.
Public markets see the outcome. We invest in the interim. Through primary participation in growth rounds and disciplined secondary acquisition, we provide capital where it is most catalytic — and build positions in the businesses that others can no longer access.
Our edge is relational, not algorithmic. Knowledge, in this corner of the market, is genuinely esoteric.
Pre-IPO growth equity in technology. Late-stage private positions in category-defining businesses with established traction, defensible economics, and a credible path to public-market liquidity.
The mandate is access at the late-private stage — not early-stage discovery.
Esoteric Investments is the sponsor of Esoteric Strategies LP, a series limited partnership. Each investment is held in its own dedicated series, with its own investor base, structure, and economics.
There is no commingled fund. Capital is matched precisely to opportunity, deal by deal.
We lead and co-invest in growth-stage primary rounds where our capital is genuinely additive — and our network meaningfully so. Cheque sizes from $25M to $200M, with appetite to anchor.
We provide structured liquidity to founders, employees, and early investors in the most sought-after private companies — discreetly, efficiently, and at scale. Single-name and tender-led transactions.
The best returns live in places that are difficult to access, harder to underwrite, and rarely covered.
Chief Investment Officer of BNB Plus Corp (Nasdaq: BNBX), a public digital asset treasury built to outperform simple BNB buy-and-hold through a yield and compounding mechanism.
Chief Investment Officer of Horsman Holdings since 2018, leading allocation across hedge funds, private equity, real estate, and direct venture.
Co-Founder and Chief Investment Officer of HealthRamp Partners, a healthcare-focused venture capital firm.
We do not publish a public portfolio. The companies we back operate at the frontier of technology, defense, and infrastructure; many of our positions are sensitive, our counterparties confidential, and our holdings concentrated.
Discretion is not a marketing posture — it is a service we extend to the founders and shareholders who entrust us with capacity, access, and information.
Limited partners, prospective co-investors, and counterparties evaluating a potential transaction are invited to request access through our diligence process.
Request Access →We work with a small circle of founders, secondary sellers, co-investors, and limited partners. Discretion is presumed; introductions are warmly received.
Legal Review Required
This website is provided for informational purposes only. It does not constitute an offer to sell or a solicitation of an offer to buy any securities or interests in any fund or investment vehicle.
Any such offer or solicitation will be made solely through definitive offering documents furnished to qualified investors.
Investments in private funds involve significant risk, including the risk of loss of an investor's entire investment. Past performance is not indicative of, and is no guarantee of, future results.
Esoteric Strategies LP and its series are available only to investors who meet applicable accredited investor and qualified purchaser standards.
Counsel should review and approve final language before publication.